Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Pharmacother ; 45(7-8): 869-75, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21775690

RESUMO

BACKGROUND: Prothrombin complex concentrate (PCC) is recommended as a therapy to be considered for the reversal of warfarin's effects. Few published data are available on the use of PCC for this indication in traumatically injured patients. OBJECTIVE: To determine whether the addition of PCC to standard approaches to warfarin reversal more rapidly corrects the international normalized ratio (INR) in injured patients. METHODS: A retrospective analysis was performed in trauma patients who were on warfarin preinjury from January 2007 to September 2009 at North Memorial Medical Center. Data were collected from medical records and the trauma registry. Patients were separated based on whether or not they received PCC. The groups were compared on the basis of demographics, units of fresh frozen plasma (FFP), vitamin K use, units of PCC, number of patients achieving an INR of 1.5 or less, time to an INR of 1.5 or less, mortality, intensive care unit (ICU) and hospital length of stay, and the incidence of thromboembolic events during hospitalization. RESULTS: Thirty-one patients were included in the analysis; 13 patients who received a total mean (SD) dose of 2281 (1053) units (25.6 [12.2] units/kg) of PCC (Profilnine SD) were compared to 18 patients who did not receive PCC. There was no significant difference between groups in FFP units received or the number of patients who received vitamin K. Most patients in both groups achieved an INR of 1.5 or less (92% PCC vs 89% no PCC). However, the mean time to achieve an INR of 1.5 or less was 16:59 (20:53) hours in the PCC group versus 30:03 (23:10) hours in the no PCC group (p = 0.048). There were 3 deaths in the PCC group and no deaths in the no PCC group (p = 0.06). ICU and hospital length of stay and number of thromboembolic events did not differ significantly between the 2 groups. CONCLUSIONS: PCC, when added to FFP and vitamin K, resulted in a more rapid time to reversal of the INR.


Assuntos
Anticoagulantes/efeitos adversos , Fatores de Coagulação Sanguínea/uso terapêutico , Hemorragia/terapia , Hemostáticos/uso terapêutico , Coeficiente Internacional Normatizado , Varfarina/efeitos adversos , Ferimentos e Lesões/terapia , Idoso , Idoso de 80 Anos ou mais , Anticoagulantes/antagonistas & inibidores , Cuidados Críticos , Feminino , Hemorragia/etiologia , Hemorragia/mortalidade , Humanos , Incidência , Tempo de Internação , Masculino , Prontuários Médicos , Pessoa de Meia-Idade , Minnesota/epidemiologia , Sistema de Registros , Estudos Retrospectivos , Tromboembolia/epidemiologia , Varfarina/antagonistas & inibidores , Ferimentos e Lesões/mortalidade , Ferimentos e Lesões/fisiopatologia
2.
J Wound Ostomy Continence Nurs ; 38(4): 433-45, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21747261

RESUMO

PURPOSE: The purpose of this study was to determine the time to development, severity, and risk factors of incontinence-associated dermatitis (IAD) among critically ill patients with fecal incontinence. SUBJECTS AND SETTING: Forty-five patients with a mean age of 49.4 ± 18.5 years (mean ± SD) in the surgical/trauma critical care unit (ICU) of 1 of 3 urban hospitals who were free of any perineal skin damage at study start participated in the study. The majority (76%) were male. METHODS: Surveillance of skin for IAD and chart review of data initially and daily. RESULTS: Incontinence-associated dermatitis developed in 36% of patients. The median time to onset of IAD was 4 days (range, 1-6). Eighty-one percent of patients still had IAD at discharge from the ICU and at the end of their surveillance (median time = 7 days, range, 1-19 days). The severity of erythema associated with IAD was mild, moderate, or severe for 13%, 11%, or 4% (means) of the time patients were observed. Denudement occurred 9% of the observed time. Frequent incontinence of loose or liquid stools and diminished cognitive awareness were significant independent risk factors for development of IAD sooner. CONCLUSION: Incontinence-associated dermatitis develops in critically ill patients with fecal incontinence relatively quickly and does not resolve in most before their discharge from the ICU. Early monitoring and prevention of IAD, especially in patients with diminished cognition or with frequent leakage of loose or liquid feces, are recommended to promote skin health.


Assuntos
Dermatite Irritante/epidemiologia , Dermatite Irritante/etiologia , Incontinência Fecal/complicações , Higiene da Pele/métodos , Adulto , Idoso , Estudos de Coortes , Estado Terminal/terapia , Dermatite Irritante/enfermagem , Feminino , Seguimentos , Humanos , Unidades de Terapia Intensiva , Masculino , Pessoa de Meia-Idade , Diagnóstico de Enfermagem , Estudos Prospectivos , Medição de Risco , Índice de Gravidade de Doença , Fatores de Tempo , Resultado do Tratamento
3.
J Trauma Nurs ; 15(3): 91-3, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18820554

RESUMO

The clinical nurse specialist (CNS) is included in the collective term advanced practice nurse. Preparation of the CNS involves completion of a graduate program with a clinical focus, specialty certification, and state-defined requirements for licensure.The trauma CNS demonstrates advanced clinical knowledge based on an in-depth understanding of the pathophysiology of trauma combined with extensive practical experience observing human responses to injury. The trauma CNS assumes the traditional subroles as expert practitioner, educator, consultant, and researcher with the proportion of time spent in each subrole based on the needs of the trauma program. The CNS's ability to minimize variances in care and prevent adverse outcomes directly support performance improvement. The Society of Trauma Nurses recognizes and supports the utilization of CNSs in trauma programs.


Assuntos
Enfermeiros Clínicos/organização & administração , Papel do Profissional de Enfermagem , Especialidades de Enfermagem/organização & administração , Traumatologia/organização & administração , Certificação , Educação de Pós-Graduação em Enfermagem , Humanos , Descrição de Cargo , Licenciamento em Enfermagem , Privilégios do Corpo Clínico , Enfermeiros Clínicos/educação , Autonomia Profissional , Competência Profissional , Especialidades de Enfermagem/educação , Traumatologia/educação , Estados Unidos , Ferimentos e Lesões/enfermagem
4.
J Adv Nurs ; 62(3): 354-64, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18426460

RESUMO

AIM: This paper is a report of a study to determine the incidence of non-Clostridium difficile-associated diarrhoea in hospitalized patients and to re-evaluate clinical characteristics and other risk factors related to non-C. difficile-associated diarrhoea. BACKGROUND: Numerous factors are thought to be responsible for diarrhoea in hospitalized patients. Reports about the diarrhoeal effects of some medications administered concomitantly with tube feeding have stimulated reappraisal of the influence of tube feeding as a potential cause. METHOD: This study was a secondary analysis of data of 154 hospitalized patients collected during a prospective epidemiological study from 1992 to 1993. The secondary analysis was completed in 2006 in order to investigate unanswered questions of current importance. FINDINGS: The sample was predominantly male and middle aged; approximately 50% were tube fed, and 25% were in an intensive care unit. The incidence of diarrhoea was 35%. Increased severity of illness as well as the combination of sorbitol-containing medication administration and tube feeding were found to be statistically significant factors in the development of diarrhoea. CONCLUSION: As diarrhoea in hospitalized patients appears to be multifactorial, use of an algorithm to systematically evaluate and manage related factors is recommended.


Assuntos
Diarreia/epidemiologia , Nutrição Enteral/efeitos adversos , Hospitalização , Sorbitol/efeitos adversos , Edulcorantes/efeitos adversos , Doença Aguda , Idoso , Diarreia/classificação , Diarreia/etiologia , Estudos Epidemiológicos , Feminino , Humanos , Tempo de Internação , Modelos Logísticos , Masculino , Fatores de Risco , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...